Literature DB >> 24076169

Synthesis of azide derivative and discovery of glyoxalase pathway inhibitor against pathogenic bacteria.

Benson Edagwa1, Yiran Wang, Prabagaran Narayanasamy.   

Abstract

A glyoxalase inhibitor was synthesized and tested against Staphylococcus aureus for first time and showed MIC90 of 20 μg/ml. Henceforth, we synthesized unnatural azide derivative of the same inhibitor to improve the biological activity. In that order, an azide carboxylate was synthesized from dimethyl tartrate by tosylation and azide substitution. The synthesized, azide compound was coupled with glutathione derivative in high yield and tested against S. aureus and showed improved MIC90 of 5 μg/ml. In general, it can be also easily converted to unnatural β-amino acid in good yield. The shown methodology will be extended to study induced suicide in Burkholderia mallei, Francisella tularensis and Mycobacterium tuberculosis in future.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Glutathione derivative; Glyoxalase pathway; Inhibitor; Metabolism; Staphylococcus aureus

Mesh:

Substances:

Year:  2013        PMID: 24076169      PMCID: PMC3833347          DOI: 10.1016/j.bmcl.2013.09.011

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  15 in total

1.  Discovery of 1,4-dihydroxy-2-naphthoate [corrected] prenyltransferase inhibitors: new drug leads for multidrug-resistant gram-positive pathogens.

Authors:  Michio Kurosu; Prabagaran Narayanasamy; Kallolmay Biswas; Rakesh Dhiman; Dean C Crick
Journal:  J Med Chem       Date:  2007-07-21       Impact factor: 7.446

2.  Specific cleavage of peptides at cysteinyl residues.

Authors:  Y Degani; A Patchornik; J A Maclaren
Journal:  J Am Chem Soc       Date:  1966-07-20       Impact factor: 15.419

Review 3.  Methylglyoxal production in bacteria: suicide or survival?

Authors:  G P Ferguson; S Tötemeyer; M J MacLean; I R Booth
Journal:  Arch Microbiol       Date:  1998-10       Impact factor: 2.552

4.  Characterization of glyoxalase I (E. coli)-inhibitor interactions by electrospray time-of-flight mass spectrometry and enzyme kinetic analysis.

Authors:  E Stokvis; S L Clugston; J F Honek; A J Heck
Journal:  J Protein Chem       Date:  2000-07

5.  Trypanothione-dependent glyoxalase I in Trypanosoma cruzi.

Authors:  Neil Greig; Susan Wyllie; Tim J Vickers; Alan H Fairlamb
Journal:  Biochem J       Date:  2006-12-01       Impact factor: 3.857

6.  Glyoxalase I from Leishmania donovani: a potential target for anti-parasite drug.

Authors:  Prasad K Padmanabhan; Angana Mukherjee; Sushma Singh; Swati Chattopadhyaya; Venkataraman S Gowri; Peter J Myler; Narayanaswamy Srinivasan; Rentala Madhubala
Journal:  Biochem Biophys Res Commun       Date:  2005-10-07       Impact factor: 3.575

7.  Enantioselective synthesis of alpha,beta-disubstituted-beta-amino acids.

Authors:  Mukund P Sibi; Narayanasamy Prabagaran; Sandeep G Ghorpade; Craig P Jasperse
Journal:  J Am Chem Soc       Date:  2003-10-01       Impact factor: 15.419

8.  Explaining the inhibition of glyoxalase II by 9-fluorenylmethoxycarbonyl-protected glutathione derivatives.

Authors:  Ke-Wu Yang; Daniel N Sobieski; Anne L Carenbauer; Patrick A Crawford; Christopher A Makaroff; Michael W Crowder
Journal:  Arch Biochem Biophys       Date:  2003-06-15       Impact factor: 4.013

Review 9.  Glutathione--functions and metabolism in the malarial parasite Plasmodium falciparum.

Authors:  Katja Becker; Stefan Rahlfs; Christine Nickel; R Heiner Schirmer
Journal:  Biol Chem       Date:  2003-04       Impact factor: 3.915

10.  Expression and characterization of soluble 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase from bacterial pathogens.

Authors:  Hyungjin Eoh; Prabagaran Narayanasamy; Amanda C Brown; Tanya Parish; Patrick J Brennan; Dean C Crick
Journal:  Chem Biol       Date:  2009-12-24
View more
  7 in total

1.  Discovery of bicyclic inhibitors against menaquinone biosynthesis.

Authors:  Seoung-ryoung Choi; Marilynn A Larson; Steven H Hinrichs; Amanda M Bartling; Joel Frandsen; Prabagaran Narayanasamy
Journal:  Future Med Chem       Date:  2016-01       Impact factor: 3.808

2.  Prolonged-acting, multi-targeting gallium nanoparticles potently inhibit growth of both HIV and mycobacteria in co-infected human macrophages.

Authors:  Prabagaran Narayanasamy; Barbara L Switzer; Bradley E Britigan
Journal:  Sci Rep       Date:  2015-03-06       Impact factor: 4.379

3.  Long-acting antituberculous therapeutic nanoparticles target macrophage endosomes.

Authors:  Benson J Edagwa; Dongwei Guo; Pavan Puligujja; Han Chen; JoEllyn McMillan; Xinming Liu; Howard E Gendelman; Prabagaran Narayanasamy
Journal:  FASEB J       Date:  2014-08-13       Impact factor: 5.191

4.  Flavonoid Enhances the Glyoxalase Pathway in Cerebellar Neurons to Retain Cellular Functions.

Authors:  Joel Frandsen; Prabagaran Narayanasamy
Journal:  Sci Rep       Date:  2017-07-11       Impact factor: 4.379

Review 5.  Neuroprotection through flavonoid: Enhancement of the glyoxalase pathway.

Authors:  Joel R Frandsen; Prabagaran Narayanasamy
Journal:  Redox Biol       Date:  2017-10-18       Impact factor: 11.799

6.  Divergent synthesis of chiral cyclic azides via asymmetric cycloaddition reactions of vinyl azides.

Authors:  Nuligonda Thirupathi; Fang Wei; Chen-Ho Tung; Zhenghu Xu
Journal:  Nat Commun       Date:  2019-07-18       Impact factor: 14.919

7.  Comprehensive Examination of the Mouse Lung Metabolome Following Mycobacterium tuberculosis Infection Using a Multiplatform Mass Spectrometry Approach.

Authors:  Miguel Fernández-García; Fernanda Rey-Stolle; Julien Boccard; Vineel P Reddy; Antonia García; Bridgette M Cumming; Adrie J C Steyn; Serge Rudaz; Coral Barbas
Journal:  J Proteome Res       Date:  2020-04-23       Impact factor: 4.466

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.